Clinical Trial Update: This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pharmacokinetics, pharmacodynamics, and safety of Replagal produced by two manufacturing processes in Fabry disease; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• Replagal (agalsidase alfa)

Snippet

Sponsor: Shire | Conditions: Fabry Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-04-25